Honors Coreg Researchers at Capitol Hill Press Conference
WASHINGTON, Feb. 7 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) today honored recipients of PhRMA's 2008 Discoverers Award and this year's Clinical Trial Exceptional Service Award at a Capitol Hill news conference.
PhRMA presented the Discoverers Award -- its highest honor -- and the Clinical Trial Exceptional Service Award to biopharmaceutical company scientists and other researchers who helped discover and advance Coreg, a breakthrough medicine that has helped improve the lives of more than five million patients worldwide.
GlaxoSmithKline's (GSK) cardiovascular medicine Coreg has reduced the mortality of congestive heart failure and changed the paradigm for treating this life-threatening and debilitative disease. Coreg is also used by patients to treat high blood pressure and prevent recurrent heart attacks.
This year marks the 20-year anniversary of the Discoverers Award. The award recognizes scientists whose research and development of medicines have greatly benefited mankind, and whose dedication to improving the quality of patients' lives exemplify the best among research based company scientists today.
This year, PhRMA presented the Discoverers Award to the three then SmithKline Beecham scientists who discovered the prescription drug Coreg. The recipients of the award are Eliot Ohlstein, Ph.D., Senior Vice President and head of the Cardiovascular & Urogenital Diseases Center of Excellence for Drug Discovery at GSK; Robert Ruffolo, Jr., Ph.D., formerly an R&D executive at the GSK heritage company and now President, Research & Development at Wyeth; and Tian-Li Yue, Ph.D., Manager, Department of Investigative & Cardiac Biology, Cardiovascular Urogenital Centre of Excellence in Drug Discovery at GSK. All of these honorees reside in the Philadelphia, Pennsylvania area.
At the press conference, PhRMA also
|SOURCE Pharmaceutical Research and Manufacturers of America|
Copyright©2008 PR Newswire.
All rights reserved